Predictors of clinical outcomes of hospitalized patients with primary sclerosing cholangitis in the United States.
作者信息
Alsakarneh Saqr, Duong Nikki
机构信息
Department of Internal Medicine, University of Missouri-Kansas City, Kansas City, Missouri USA.
Division of Gastroenterology/Hepatology, Department of Medicine, Stanford University School of Medicine, Palo Alto, California USA.
出版信息
Proc (Bayl Univ Med Cent). 2023 Sep 13;36(6):705. doi: 10.1080/08998280.2023.2257104. eCollection 2023.
Abstract
摘要
相似文献
1
Predictors of clinical outcomes of hospitalized patients with primary sclerosing cholangitis in the United States.美国原发性硬化性胆管炎住院患者临床结局的预测因素
Proc (Bayl Univ Med Cent). 2023 Sep 13;36(6):705. doi: 10.1080/08998280.2023.2257104. eCollection 2023.
2
Primary sclerosing cholangitis hospitalizations in the United States: characteristics and predictors of clinical outcomes.美国原发性硬化性胆管炎的住院情况：临床结局的特征及预测因素
Proc (Bayl Univ Med Cent). 2023 Sep 14;36(6):700-704. doi: 10.1080/08998280.2023.2254196. eCollection 2023.
3
The course of colonic disease in ulcerative colitis patients with primary sclerosing cholangitis.
Turk J Gastroenterol. 2002 Sep;13(3):134-8.
4
Pharmacological interventions for primary sclerosing cholangitis: an attempted network meta-analysis.原发性硬化性胆管炎的药物干预：一项网状Meta分析尝试
Cochrane Database Syst Rev. 2017 Mar 28;3(3):CD011343. doi: 10.1002/14651858.CD011343.pub2.
5
A case report on severe nivolumab-induced adverse events similar to primary sclerosing cholangitis refractory to immunosuppressive therapy.一例严重 nivolumab 诱导的不良反应病例报告，类似于原发性硬化性胆管炎，对免疫抑制治疗难治。
Medicine (Baltimore). 2021 Jun 11;100(23):e25774. doi: 10.1097/MD.0000000000025774.
6
Does colitis associated with primary sclerosing cholangitis represent an actual subset of ulcerative colitis?与原发性硬化性胆管炎相关的结肠炎是否代表溃疡性结肠炎的一个实际亚组？
Hepatogastroenterology. 2003 Nov-Dec;50(54):1830-5.
7
Different immunosuppressive regimens and recurrence of primary sclerosing cholangitis after liver transplantation.不同免疫抑制方案与肝移植后原发性硬化性胆管炎的复发
Liver Transpl. 2003 Jul;9(7):727-32. doi: 10.1053/jlts.2003.50143.
8
Surgery for segmental primary sclerosing cholangitis.节段性原发性硬化性胆管炎的手术治疗
Hepatogastroenterology. 2004 May-Jun;51(57):668-71.
9
Glucocorticosteroids for primary sclerosing cholangitis.用于原发性硬化性胆管炎的糖皮质激素
Cochrane Database Syst Rev. 2010 Jan 20;2010(1):CD004036. doi: 10.1002/14651858.CD004036.pub3.
10
Impact of Inflammatory Bowel Disease Subtypes on the Post-liver Transplant Outcomes of Patients with Primary Sclerosing Cholangitis.炎症性肠病亚型对原发性硬化性胆管炎患者肝移植后结局的影响。
Dig Dis Sci. 2023 Sep;68(9):3781-3800. doi: 10.1007/s10620-023-08023-y. Epub 2023 Jul 14.
本文引用的文献
1
Primary sclerosing cholangitis hospitalizations in the United States: characteristics and predictors of clinical outcomes.美国原发性硬化性胆管炎的住院情况：临床结局的特征及预测因素
Proc (Bayl Univ Med Cent). 2023 Sep 14;36(6):700-704. doi: 10.1080/08998280.2023.2254196. eCollection 2023.
2
Primary sclerosing cholangitis.原发性硬化性胆管炎
Inflamm Bowel Dis. 2005 Jan;11(1):62-72. doi: 10.1097/00054725-200501000-00009.
3
Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community.美国一个社区中原发性硬化性胆管炎的发病率、临床谱及预后
Gastroenterology. 2003 Nov;125(5):1364-9. doi: 10.1016/j.gastro.2003.07.011.
4
Primary sclerosing cholangitis.原发性硬化性胆管炎
Hepatology. 1999 Jul;30(1):325-32. doi: 10.1002/hep.510300101.
Zotero 插件